PharmaCielo Ltd.
PCLOF
$0.05
$0.0131.30%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 434.80K | 645.50K | 233.10K | 805.10K | 974.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 434.80K | 645.50K | 233.10K | 805.10K | 974.30K |
| Cost of Revenue | -285.20K | 1.01M | 277.00K | 460.10K | 701.80K |
| Gross Profit | 720.00K | -360.60K | -43.90K | 344.90K | 272.60K |
| SG&A Expenses | 230.60K | 1.56M | 600.90K | 738.20K | 903.80K |
| Depreciation & Amortization | 2.90K | 35.30K | 14.50K | 15.00K | 34.90K |
| Other Operating Expenses | -653.80K | -33.40K | -128.60K | -126.10K | -26.50K |
| Total Operating Expenses | -705.50K | 2.57M | 763.80K | 1.09M | 1.61M |
| Operating Income | 1.14M | -1.92M | -530.70K | -282.20K | -639.60K |
| Income Before Tax | 292.20K | -1.01M | -940.30K | -1.07M | -1.94M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 292.20K | -1.01M | -940.30K | -1.07M | -1.94M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 292.20K | -1.01M | -940.30K | -1.07M | -1.94M |
| EBIT | 1.14M | -1.92M | -530.70K | -282.20K | -639.60K |
| EBITDA | 1.45M | -1.86M | -516.20K | -75.80K | -611.20K |
| EPS Basic | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 187.98M | 187.98M | 187.98M | 175.27M | 162.03M |
| Average Diluted Shares Outstanding | 187.98M | 187.98M | 187.98M | 175.27M | 162.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |